Cargando…
Systemic brain tumor delivery of synthetic protein nanoparticles for glioblastoma therapy
Glioblastoma (GBM), the most aggressive form of brain cancer, has witnessed very little clinical progress over the last decades, in part, due to the absence of effective drug delivery strategies. Intravenous injection is the least invasive drug delivery route to the brain, but has been severely limi...
Autores principales: | Gregory, Jason V., Kadiyala, Padma, Doherty, Robert, Cadena, Melissa, Habeel, Samer, Ruoslahti, Erkki, Lowenstein, Pedro R., Castro, Maria G., Lahann, Joerg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655867/ https://www.ncbi.nlm.nih.gov/pubmed/33173024 http://dx.doi.org/10.1038/s41467-020-19225-7 |
Ejemplares similares
-
Targeting gliomas with STAT3-silencing nanoparticles
por: Kadiyala, Padma, et al.
Publicado: (2021) -
Systematic studies into uniform synthetic protein nanoparticles
por: Habibi, Nahal, et al.
Publicado: (2022) -
Molecular ZIP codes in targeted drug delivery
por: Ruoslahti, Erkki
Publicado: (2022) -
An Optimized Protocol for In Vivo Analysis of Tumor Cell Division in a Sleeping Beauty-Mediated Mouse Glioma Model
por: Garcia-Fabiani, Maria B., et al.
Publicado: (2020) -
Electrokinetic characterization of synthetic protein nanoparticles
por: Quevedo, Daniel F, et al.
Publicado: (2020)